ERBB2 and medullary thyroid gland carcinoma: In MTC without metastases cases, Luminal A represented 9 cases (36%), Luminal B HER-2 positive was observed in 6 cases (24%), Luminal B HER-2 negative was observed in 2 cases (8%), and no cases of HER-2 overexpression were found.